MedPath

Association between selum Klotho, sleep-disordered breathing and long term prognosis in heamodialysis patients

Not Applicable
Conditions
end stage renal disease
Registration Number
JPRN-UMIN000013307
Lead Sponsor
Division of Nephrology, Jichi Medical University
Brief Summary

We prospectively followed a cohort of 63 patients with a mean duration of chronic hemodialysis of years for a median of 65 months. Serum soluble Klotho was detectable in all patients (median 371 pg/mL, interquartile range 309 to 449). Patients with serum soluble Klotho levels below the lower quartile (<309 pg/mL) had significantly higher cardiovascular and all-cause mortality rates. Furthermore, the higher all-cause mortality persisted even after adjustment for confounders (hazard ratio 4.14, confidence interval 1.29-13.48). We conclude that there may be a threshold for the serum soluble Klotho level associated with a higher risk of mortality.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

malignat disease acute pulmonary disease patients without acceptance

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mortality
Secondary Outcome Measures
NameTimeMethod
cardiovascular event
© Copyright 2025. All Rights Reserved by MedPath